Cargando…
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
BACKGROUND: Tissue factor pathway inhibitor 2 (TFPI2) is a novel serum biomarker that discriminates ovarian clear cell carcinoma (CCC) from borderline ovarian tumors (BOTs) and non-clear cell epithelial ovarian cancers (EOCs). Here, we examined the performance of TFPI2 for preoperative diagnosis of...
Autores principales: | Miyagi, Etsuko, Arakawa, Noriaki, Sakamaki, Kentaro, Yokota, Naho Ruiz, Yamanaka, Takeharu, Yamada, Yuki, Yamaguchi, Satoshi, Nagao, Shoji, Hirashima, Yasuyuki, Kasamatsu, Yuka, Kato, Hisamori, Mogami, Tae, Miyagi, Yohei, Kobayashi, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213588/ https://www.ncbi.nlm.nih.gov/pubmed/34009487 http://dx.doi.org/10.1007/s10147-021-01914-y |
Ejemplares similares
-
Annexin A4 Is Involved in Proliferation, Chemo-Resistance and Migration and Invasion in Ovarian Clear Cell Adenocarcinoma Cells
por: Mogami, Tae, et al.
Publicado: (2013) -
Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
por: Arakawa, Noriaki, et al.
Publicado: (2016) -
Tissue factor pathway inhibitor-2 is specifically expressed in ovarian clear cell carcinoma tissues in the nucleus, cytoplasm and extracellular matrix
por: Ota, Yukihide, et al.
Publicado: (2021) -
Laparoscopic repair of the vaginal cuff dehiscence: Dehiscence occurring after the first sexual intercourse after the laparoscopic modified radical hysterectomy
por: Suzuki, Yukio, et al.
Publicado: (2018) -
Metachronous serous endometrial intraepithelial carcinoma and serous peritoneal carcinoma: analysis of probable independent lesions
por: Furuya, Mitsuko, et al.
Publicado: (2016)